ALANA STARR: Open Payments
NPI 1619642626 · MINDEN, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,715 in 83 payments from 15 companies in 2025. Trend: 2023 $758 · 2024 $1,412 · 2025 $1,715
Food & beverage: $1,715
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $451 |
| AstraZeneca Pharmaceuticals LP | 11 | $365 |
| Novo Nordisk Inc | 16 | $212 |
| PFIZER INC. | 9 | $171 |
| Lundbeck LLC | 4 | $89 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $86 |
| GlaxoSmithKline, LLC. | 3 | $61 |
| Lilly USA, LLC | 3 | $56 |
| Exact Sciences Corporation | 3 | $55 |
| Axsome Therapeutics, Inc. | 2 | $46 |
Products named: VRAYLAR, FARXIGA, NURTEC ODT, UBRELVY, BREZTRI, Rybelsus, Ozempic, REXULTI.
Industry payments across NV — which companies pay providers there.
